The genotype 3-specific hepatitis C virus core protein residue phenylalanine 164 increases steatosis in an in vitro cellular model
about
Adiponectin serum level in chronic hepatitis C infection and therapeutic profilePathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogenAutophagy in hepatitis C virus-host interactions: potential roles and therapeutic targets for liver-associated diseasesFatty liver in chronic hepatitis C infection: unravelling the mechanismsSpecific Polymorphisms in Hepatitis C Virus Genotype 3 Core Protein Associated with Intracellular Lipid AccumulationHepatitis C Virus Nonstructural 4B Protein Modulates Sterol Regulatory Element-binding Protein Signaling via the AKT PathwayDomain 3 of Hepatitis C Virus Core Protein Is Sufficient for Intracellular Lipid AccumulationPalmitoylation of Hepatitis C Virus Core Protein Is Important for Virion ProductionOrigin of hepatitis C virus genotype 3 in Africa as estimated through an evolutionary analysis of the full-length genomes of nine subtypes, including the newly sequenced 3d and 3eFull-length sequences of 11 hepatitis C virus genotype 2 isolates representing five subtypes and six unclassified lineages with unique geographical distributions and genetic variation patternsLipid Droplets in Health and Disease.Hepcidin and the iron enigma in HCV infection.Production and pathogenicity of hepatitis C virus core gene products.Viral sequence variation in chronic carriers of hepatitis C virus has a low impact on liver steatosis.Inhibition of core gene of HCV 3a genotype using synthetic and vector derived siRNAsInsulin resistance and liver steatosis in chronic hepatitis C infection genotype 3.Elevated miR-33a and miR-224 in steatotic chronic hepatitis C liver biopsiesRole of HCV Core gene of genotype 1a and 3a and host gene Cox-2 in HCV-induced pathogenesis.Hepatitis C virus infection: molecular pathways to steatosis, insulin resistance and oxidative stress"Liverscore" is predictive of both liver fibrosis and activity in chronic hepatitis C.The Replacement of 10 Non-Conserved Residues in the Core Protein of JFH-1 Hepatitis C Virus Improves Its Assembly and Secretion.Interaction of metabolic syndrome, nonalcoholic fatty liver disease and chronic hepatitis C.Steatosis and insulin resistance in hepatitis C: a way out for the virus?Interaction of the hepatitis C virus (HCV) core with cellular genes in the development of HCV-induced steatosis.Lipid droplet hijacking by intracellular pathogens.Organelle dysfunction in hepatitis C virus-associated steatosis: anything to learn from nonalcoholic steatohepatitis?Impact of HCV genetic differences on pathobiology of disease.Do hepatitis B virus and hepatitis C virus co-infections increase hepatocellular carcinoma occurrence through synergistically modulating lipogenic gene expression?Hepatitis C virus diversity and hepatic steatosis.The predictive value of steatosis in hepatitis C virus infection.Increased hepatic expression of miRNA-122 in patients infected with HCV genotype 3.Lipid droplet binding of hepatitis C virus core protein genotype 3.Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs.Role of hepatitis C virus proteins (C, NS3, NS5A) in hepatic oncogenesis.
P2860
Q26827639-43E6FE65-C409-4B33-A027-41356C5D7B8DQ26861095-A0AE55EA-FC52-42F7-A4C0-290B3F102A3DQ26992256-BF837FA9-A33E-4853-8D0E-2309A654D8B1Q27481041-E6A999AA-6C4F-4CF1-8BB6-534D727E4795Q27486390-A381F7D0-F4AC-4973-ABE6-7A149550C354Q27488294-78652346-68DD-438A-ABE9-C0FB5833F14EQ27490435-B040AD94-6C2F-49F7-81C2-F9AE5161B02AQ27490522-C54E4848-ED99-48E1-AC24-565CB8015D42Q28655567-320298DF-6D6C-4D7C-9BC7-7F3A8679E177Q28681404-9E079748-1303-4394-A02F-677B60094112Q32174749-B0F2059C-3393-403F-8B72-AC05099A0AFBQ33779089-29D48D16-8E62-4B2C-AE5D-1102824F1A5AQ33780095-4FD52DD1-CB4A-4B35-BEC7-E5B9CE007F1FQ34221618-C76F1333-E4A1-4562-820F-923D0D95C6CAQ34351097-552E76D0-71DA-4A38-9012-4F0FEB02AE23Q34467208-34B2E4A1-30D0-4836-A53A-54403748C0AAQ34467266-72BCFE80-176E-4869-863A-EE671BFDA422Q34832969-860E33B1-C395-4448-BD8F-1D0B2AEFA2B7Q35259669-7F11D765-EA51-4B2B-88F0-42CAA8EE22FDQ35575885-00CF6721-031F-419A-A64D-7F903B56807DQ35764429-2560179B-1F77-4F9F-89D2-017E0A7CF6A3Q37345868-07695520-8157-4C0B-94A0-711D4652DD62Q37622162-335B6C92-E134-4A59-9DED-743A6242A010Q37788976-FD55CDB8-8A67-4211-8DCC-C1A1E18F0F0BQ37835452-AB23CA30-DA4D-441D-AB2C-F605723EB59BQ37863141-550FE634-C1CC-424C-8B58-D9999FA0064AQ37929753-5237DCD7-F03B-4F62-8324-29A2DE73C478Q38001126-A95285E3-2C8F-448C-89F1-456AEA20A4BBQ38072721-12223A62-252B-4BBD-9F1E-141653D50232Q38085061-CEE28723-AEF0-46E7-A2E1-E6402D8F82DCQ39322111-6B3A0BEB-3404-4426-B64D-AE0579613FC6Q42244227-BAC5D2A8-5B4F-4064-810D-51C2E4586F2FQ42984512-FB74015C-4363-45EC-BD26-16F2739E0BC8Q45399951-77CAC64E-DAF9-4091-A981-DD59224472F2
P2860
The genotype 3-specific hepatitis C virus core protein residue phenylalanine 164 increases steatosis in an in vitro cellular model
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
The genotype 3-specific hepati ...... in an in vitro cellular model
@ast
The genotype 3-specific hepati ...... in an in vitro cellular model
@en
The genotype 3-specific hepati ...... in an in vitro cellular model
@nl
type
label
The genotype 3-specific hepati ...... in an in vitro cellular model
@ast
The genotype 3-specific hepati ...... in an in vitro cellular model
@en
The genotype 3-specific hepati ...... in an in vitro cellular model
@nl
prefLabel
The genotype 3-specific hepati ...... in an in vitro cellular model
@ast
The genotype 3-specific hepati ...... in an in vitro cellular model
@en
The genotype 3-specific hepati ...... in an in vitro cellular model
@nl
P2093
P2860
P356
P1433
P1476
The genotype 3-specific hepati ...... in an in vitro cellular model
@en
P2093
C Hourioux
E Blanchard
P Roingeard
S Trassard
P2860
P304
P356
10.1136/GUT.2006.108647
P407
P577
2007-01-09T00:00:00Z